We are live on ! Find out more
TCON

TRACON Pharmaceuticals, Inc. Common Stock

Delisted

TCON was delisted on the 27th of June, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
OM
1
Opaleye Management
Massachusetts
$8.3M +$252K +5,005 +3%
IC
2
Ikarian Capital
Texas
$7.48M +$382K +7,606 +6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.55M -$251K -4,997 -14%
LA
4
Linden Advisors
New York
$1.2M +$429K +8,534 +60%
NMC
5
NEA Management Company
Maryland
$912K
BlackRock
6
BlackRock
New York
$788K -$4.68K -93 -0.6%
BFM
7
Boothbay Fund Management
New York
$706K
Two Sigma Advisers
8
Two Sigma Advisers
New York
$550K -$309K -6,150 -37%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$402K +$23K +457 +6%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$374K +$144K +2,859 +67%
JJ
11
Johnson & Johnson
New Jersey
$221K
Two Sigma Investments
12
Two Sigma Investments
New York
$217K -$296K -5,895 -59%
State Street
13
State Street
Massachusetts
$198K +$5.53K +110 +3%
TI
14
Telemetry Investments
New York
$176K -$13.8K -275 -8%
Citadel Advisors
15
Citadel Advisors
Florida
$131K +$70.3K +1,398 +128%
DY
16
Dowling & Yahnke
California
$125K
Franklin Resources
17
Franklin Resources
California
$115K
Renaissance Technologies
18
Renaissance Technologies
New York
$77K -$457K -9,090 -86%
ACM
19
ACT Capital Management
Pennsylvania
$75K
CL
20
CSS LLC
Illinois
$74K +$23.5K +468 +50%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$51K
XSC
22
X-Square Capital
Puerto Rico
$47K
Northern Trust
23
Northern Trust
Illinois
$46K
CG
24
Cutler Group
California
$42K
H
25
HoyleCohen
California
$34K